Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33981343)
Watch
English
Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
title
Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae
(English)
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
main subject
Streptococcus pneumoniae
1 reference
based on heuristic
inferred from title
author
Xilin Zhao
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
author name string
J M Blondeau
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
G Hansen
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
K Drlica
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
language of work or name
English
0 references
publication date
1 February 2001
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
published in
Antimicrobial Agents and Chemotherapy
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
volume
45
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
page(s)
433-438
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
issue
2
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
cites work
Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
A review of clinical trials with fluoroquinolones with an emphasis on new agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory se
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Pharmacokinetics and pharmacodynamics of fluoroquinolones
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Primary targets of fluoroquinolones in Streptococcus pneumoniae.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Multidrug resistance--a sign of the times.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Pharmacokinetics of grepafloxacin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Drug resistance in mycobacteria
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Development of resistance during antibiotic therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
5 July 2018
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90309
retrieved
29 October 2018
Bacterial counts in cerebrospinal fluid of children with meningitis
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/11158737
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1128/AAC.45.2.433-438.2001
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
PMCID
90309
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
PubMed ID
11158737
1 reference
stated in
Europe PubMed Central
PMCID
90309
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11158737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
